Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents

Carlos Zamora, Mariona Riudavets, Geòrgia Anguera, Letícia Alserawan, Ivana Sullivan, Andrés Barba, Jorgina Serra, Ma Àngels Ortiz, Pablo Gallardo, Lídia Perea, Javier Gavira, Agustí Barnadas, Margarita Majem, Sílvia Vidal